Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Periodontitis is a chronic inflammatory disease that leads to the destruction of the supporting tissues of the teeth. Non-surgical periodontal treatment is the first-line approach for the management of periodontitis; however, the use of adjunctive therapeutic agents may improve clinical outcomes.
The aim of this randomized clinical trial is to evaluate the effects of hyaluronic acid gel and albumin platelet-rich fibrin (Alb-PRF) used as adjuncts to non-surgical periodontal treatment on clinical and biochemical parameters in patients with Stage III periodontitis. Participants will be randomly allocated into three groups: an Alb-PRF group, a hyaluronic acid gel group, and a control group receiving non-surgical periodontal treatment alone. Clinical periodontal parameters and biochemical markers obtained from gingival crevicular fluid will be assessed at baseline and at 1 and 3 months after treatment. The findings of this study are expected to contribute to the evaluation of the potential benefits of adjunctive biological and anti-inflammatory applications in the non-surgical periodontal treatment of patients with Stage III periodontitis.v
This study is designed as a randomized, parallel-group clinical trial conducted in patients diagnosed with Stage III periodontitis. The aim of the study is to evaluate the adjunctive effects of hyaluronic acid gel and albumin platelet-rich fibrin (Alb-PRF) when used in addition to non-surgical periodontal treatment.
A total of 51 systemically healthy volunteers will be included in the study. Participants will be randomly allocated into three groups (17 patient per group). At the initial visit, all participants will undergo clinical periodontal examination, intraoral photography, and gingival crevicular fluid sampling. Supragingival scaling will be performed for all patients at baseline. One week later, full-mouth scaling and root planing will be completed in a single session.
In the Alb-PRF group, albumin platelet-rich fibrin will be applied as an adjunctive therapy. In the hyaluronic acid group, hyaluronic acid gel will be applied following scaling and root planing and the application will be repeated at the second week. The control group will receive non-surgical periodontal treatment alone without any adjunctive application. Adjunctive treatments will be applied subgingivally immediately after periodontal therapy and one week later.
To evaluate clinical and biochemical outcomes, clinical periodontal parameters and gingival crevicular fluid samples will be collected at baseline and at 1 and 3 months after treatment. Gingival crevicular fluid samples will be obtained using sterile paper strips as a non-invasive method. All collected data will be evaluated at the end of the study. The results of this study are expected to provide additional evidence regarding the effectiveness of adjunctive biological and anti-inflammatory approaches in the non-surgical treatment of Stage III periodontitis.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Alb-PRF | Experimental | Participants receive non-surgical periodontal treatment with adjunctive application of albumin platelet-rich fibrin (Alb-PRF). |
|
| Hyaluronic Acid | Experimental | Participants receive non-surgical periodontal treatment with adjunctive hyaluronic acid gel application. |
|
| Control Group | Active Comparator | Participants receive non-surgical periodontal treatment alone without any adjunctive application. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Non-Surgical Periodontal Treatment | Procedure | Supragingival scaling was performed at baseline. One week later, full-mouth scaling and root planing were completed in a single session using standard periodontal instruments. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Gingival Crevicular Fluid VEGF Levels | Changes in vascular endothelial growth factor (VEGF) levels in gingival crevicular fluid will be analyzed to evaluate angiogenic activity. | Baseline, 1. month and 3. months |
| Change in Gingival Crevicular Fluid IL-1 Beta Levels | Changes in interleukin-1 beta (IL-1β) levels in gingival crevicular fluid will be assessed as a marker of inflammation. | Baseline, 1. month and 3. months |
| Change in Gingival Crevicular Fluid IL-10 Levels | Changes in interleukin-10 (IL-10) levels in gingival crevicular fluid will be evaluated to assess anti-inflammatory response. | Baseline, 1. month and 3. months |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Probing Pocket Depth | Changes in probing pocket depth (PPD) measured in millimeters (mm) will be evaluated. | Baseline, 1. month and 3. months |
| Change in Plaque Index | Changes in plaque index scores will be evaluated. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Furkan KuÅŸoÄŸlu | Inonu University, Department of Periodontology Faculty of Dentistry | Principal Investigator |
| Arife Sabancı, Dr | Inonu University, Department of Periodontology Faculty of Dentistry | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Inonu University Faculty of Dentistry | Malatya | Battalgazi | 44280 | Turkey (Türkiye) |
Individual participant data will not be shared. This study is conducted as a academic thesis and includes sensitive clinical and biochemical data derived from gingival crevicular fluid samples. Although data will be analyzed and reported in aggregate form, sharing individual-level data may compromise participant confidentiality. In addition, institutional and national regulations restrict data sharing without additional ethics approval and explicit participant consent.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010518 | Periodontitis |
| D010510 | Periodontal Diseases |
| ID | Term |
|---|---|
| D009059 | Mouth Diseases |
| D009057 | Stomatognathic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D014080 | Tooth Exfoliation |
| D016745 | Root Planing |
| D006820 | Hyaluronic Acid |
| ID | Term |
|---|---|
| D009063 | Dental Physiological Phenomena |
| D055688 | Digestive System and Oral Physiological Phenomena |
| D012534 | Dental Scaling |
| D003777 | Dental Prophylaxis |
Not provided
Not provided
This is a three-arm, randomized, parallel-group clinical trial evaluating non-surgical periodontal therapy alone versus adjunctive hyaluronic acid gel or albumin platelet-rich fibrin (Alb-PRF) in patients with Stage III periodontitis
Not provided
Not provided
Not provided
Not provided
|
| Albumin Platelet-Rich Fibrin (Alb-PRF) | Other | Albumin platelet-rich fibrin (Alb-PRF) was applied subgingivally as an adjunctive therapy immediately after non-surgical periodontal treatment, with a second application performed one week later. |
|
| Hyaluronic Acid Gel | Other | Hyaluronic acid gel was applied subgingivally as an adjunct to non-surgical periodontal treatment immediately after the procedure, with a second application performed one week later. |
|
|
| Baseline, 1. month and 3. months |
| Change in Gingival Index | Changes in gingival index scores will be evaluated. | Baseline, 1. month and 3. months |
| Change in Bleeding on Probing | Changes in bleeding on probing (BOP), expressed as the percentage of bleeding sites (%), will be evaluated as an indicator of gingival inflammation. | Baseline, 1 month and 3 months |
| Change in Clinical Attachment Level | Changes in clinical attachment level (CAL) measured in millimeters (mm) will be evaluated. | Baseline, 1. month and 3. months |
| D010517 | Periodontics |
| D003813 | Dentistry |
| D013357 | Subgingival Curettage |
| D011313 | Preventive Dentistry |
| D006025 | Glycosaminoglycans |
| D011134 | Polysaccharides |
| D002241 | Carbohydrates |